Isolation and susceptibility patterns of bacteria associated with lung diseases

Authors

  • Chinyelu Umeaku Department of Microbiology, Chukwuemeka Odumegwu Ojukwu University Uli, Anambra State.
  • Harrison Eze Department of Microbiology, Chukwuemeka Odumegwu Ojukwu University Uli, Anambra State.

DOI:

https://doi.org/10.30574/gscbps.2022.18.1.0293

Keywords:

Lung disease, Stretococcus pneumoniae, Asplenium bulbiferium, Antibacterial activity

Abstract

Lung diseases have been a worldwide health problem,with high endemicity in developing countries. Bronchopneumonia remains the main disease of the lung. Despite advances in modern medicine, there is no-effective drug available that stimulate lung function, offer protection to the lung from damage or help to regenerate pulmonary cells destroyed by disseminated bacteria. There is an urgent need for effective drugs to replace/supplement those in current use. This study was embarked upon to evaluate the effect of Asplenium bulbiferum leaf extracts on nosily infected mice with Streptococcus pneumoniae isolate of suspension containing 5x106 cells/ul. Streptococcus pneumoniae was obtained from human specimen, identified through cultural, morphological and biochemical examination, in addition, polymerase chain reaction (PCR) technique was performed using universal primers to support the identification process. The antibacterial activity was carried out using agar well diffusion technique. Tube dilution technique was used to determine the minimum inhibition concentration (MIC) and minimum bactericidal concentration (MBC) using double fold serial dilution at concentrations of 400mg/ml to 25mg/ml. The effect of the leaf extract was evaluated by treating mus musculus mice (WBC count 4.5x103) with sub-MIC of A. bulbiferum extracts after being nosily infected with S. pneumoniae and appearance of disease septum with 11.3x103 WBC count after 5days from infection. The photochemical analysis revealed the presence of alkaloids; phenolics, tannins, saponins, flavonoids, steroids and glycosides. The ethanolic extract exhibited more activity than the aqueous extract against S.aureus most followed by S. pneumoniae, H. influenza and K. pneumoniae was the least. After treating the infected mice with the plant extract for 6 days from infection, the WBC count reduced to 5.1x103ml which is normal range and the mice were healthy with good physiological behaviour. For the infected untreated mice, the WBC and other immunological parameters remain high even after 16 days from infection. The study showed that Asplenium bulbiferum possessed antibacterial properties and could serve as alternative therapy for ameliorating lung infections.

Metrics

Metrics Loading ...

References

Abu-shanab BG, Adwan D, AbuSafiya K, Adwan C, M Abu-shanab. Antibacterial activity of Aplenium bulbiferum extracts growing in Palestine (Journal., Islamic University Gaza). 2005; 13(2): 147__153.

Asha J, Push paradan. The encyclopedia of infections diseases (3rd ed). 2008; 242__10.

Bain GA, Flower CD. Pulmonary eosinophilia. European Journal of Radiology. 2006; 23(1): 3-8.

Bodakh M, Ram B. In vitro and In vivo anti bacterial studies of Clerodendrum serratuminn. International journal of ferm plant. 2007; 20(2): 745__752.

Cheesbrough M. Medical Laboratory manual for tropical countries. 5th ed. pp 223__392. Tropical health technology publications, U.K. 2002.

Chung KT, Wong CT, Wei Huang YW, Lin Y. Tannins and human health: A critical review of Medical science Drug. 2008; 38__421.

Eddy O. Community Acquired Pneumonia. From common pathogens to Emerging Resistance. Emergency Medicine Practice. 2005; 7 (12): 30__45.

Ernst JD, O Stendahl. Phagocytosis of Bacteria and Bacterial Pathogenicity. Cambridge University Press, Cambridge. 2006.

Farooq A, Sajid L, Muhammad A, Anwarul Hassan G. Asplenium bulbiferum: a food plant with multiple medicinal uses. Phytotherapy Research. 2007; 21(3): 17 __25.

Gina N, Anitha J, Emilin RR. Isolation, analysis and identification of phytochemicals of antimicrobial activity of Asplenium bulbiferum. Current Biotica. 2009; 3(1): 33__37.

Goden B, Touito E, Rubenstein A, Athamna M. A new approach for a treatment of deep akin infection by an ethosomal antibiotic preparation: An invivo study. Journal of Antimicrobial Chemotherapy. 2005; 55(1): 989__994.

Gulmez M, N Oral, L Vatansever. The effect of water extract of A. bulbiferum(ibu) and lactic acid on decontamination and treatment of bacterial infections. Advance Medicine and Sciences. 2006; 85(3): 1466__1471.

Gupta A. Diagnosis and management of pneumonia and other respiratory infections (2nd edn). Professional Communications. Caddo. 2004; 28-29.

Henderson B, Oyston PCF. Bacterial Evasion of Host Immune Respones: Advance Molecular and Cellular Microbiology. pp. 22-39 Cambridge University Press, United Kingdom. 2003.

Hoffman R, Benz EJ, Shatill SJ, Furie B, Cohn HJ, Siberstein LE, McGlave P. Hematology: Basic principles and Practice. 4th (edn). 2000; 88-100.

Khare PB. Ferns and ferm allies, they are significant and fantastic. In applied Botany abstracts. 1996; 16: 18__30.

Khare PB, Adekunle AS. Preliminary assessment of antimicrobial properties of aqueous extract of plants against infections diseases. Biology and Medicines. 2009; 1(3): 20__30.

Kumar D, Prassad DN, Parkash M, Bhat N. Antibacterial activity of ethanolic extracts of aerva alanatal, in pharmacology online. Journal of Ferm Plant. 2009; 22(3): 1075__1081.

Martines A. Community acquired bacterial pneumonia. Expert Opinion Pharmacotherapy. 2007; 11(3): 336__341.

Mullis K, Kelly C, Harryz C. The unusual origin of the polymerase chain reaction. Scientific American Journal. 2009; 262(4): 56__61.

Nester NC, Roberts TO, Anderson R, Nester KO. Definition, characteristics and origin of lung infectious disease. A human perspective Microbiology 2nd edition. 2000; 130__144.

Nwobu AW, Ezike AC, Nwafor SV, Okoli CO, Enwerem NM. Evaluation of the antibacterial property of Asytasia gangetica leaf extracts. International Journal of Ethnopharmacology. 2010; 59(8): 284__295.

Provan D, CRJ Singer, T Baglin, Lilleyman J. Oxford Handbook of Clinical Hematology. New York. Oxford University Press. Inc. 2004; 163__290.

Reynold J. Laboratory Procedure Manual.on isolation of bacteria and virus. 14th ed. 2003; 191-200.

Robert AN, Peigning Y, Alison DP, Keith IB. Cardiac glycosides as noval anticancer therapeutic agents. Molecular Inventions. 2009; 88(6): 36 __59.

Scheuttpels B, Stev O, Kate M. Characteristics of some medicinal plants. Journal of Ethnopharmacology. 2007; 56(4): 7__30.

Shama SA, Mayler G, Esehun U. Radiological imaging in pneumoniae recent innovations. Current Opinion in Pulmonary Medicinal. 2007; 13(3): 159__69.

Sofowora EA. Medicinal and Traditional Medicine in Africa. London. John Wiley and Sons. 2009; 249.

Song Z, Johansen V, Faber C, Moser A, Harazm U. Ginseng treatment reduces bacterial load and lung pathology in chronic pseudomonas aeruginosa pneumonia in rats. Antimicrob. Agents. 2007; 41(5): 961__964.

Thmel H, Diem H, Haferlach T. Color atlas of hematology practical microscopic and clinical diagnostics. 2nd Ed. 2004; 181.

Tortora MV, Okubo S, Oshnishi R, Shimamura I. Effect of Ageratum conyzoides linnon clonidine and haloperidol induced catalepsy in mice. Pharmacology Online. 2005; 31(2): 186-__94.

Trease GE, Evans WC. Pharmacognosy. 15th edition. 1996; 13-21.

Virgii MC, Henry O. Antibacterial activities of some folklore medicinal plants used by tribals in Western Ghats of Inida. Journal of Pharmacolog. 2013; 51(1): 63__91

Wikipedia the free Encyclopedia. Basophilia from Wikipedia, the free encyclopedia. 2010.

World Health Organization. Epidemiology. Global tuberculosis control strategy. A Journal of Diseases Control. 2012; 66(3): 333__62.

Downloads

Published

2022-04-14

How to Cite

Umeaku, C. ., & Eze, H. . (2022). Isolation and susceptibility patterns of bacteria associated with lung diseases. GSC Biological and Pharmaceutical Sciences, 18(1), 078–092. https://doi.org/10.30574/gscbps.2022.18.1.0293

Issue

Section

Original Article